In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

High Risk Medicines Survey 2021/22

Prevalence of high risk medicines use
 
During 2021/22 there is a
 
Monthly requirement to submit data on: 
 
  1. The number of patients whose prescriptions were dispensed where all of the following conditions are met: 
 
  • Dispensed a prescription for sodium valproate or valproic acid 
  • Who are female 
  • Aged between 13 and 50 
 
  1. Of the number identified in 1. The number who participate in the Valproate Pregnancy Prevention Programme 
 
Quarterly requirement to submit data on: 
 
  1. The number of patients whose prescriptions were dispensed where all of the following conditions are met: 
 
  • Dispensed a prescription for an antipsychotic drug as specified in section 3.6 “psychoses and schizophrenia” of Chapter 4 of the BNF 
 
  • Aged 65 or over 
  1. Of the number identified in 3. The number who are resident in a care home. 
 
The schedule for data collection is as follows: 
 
Submission date on NECAF  Indicator(s)  Period to which the data relates 
May 2021  1,2  April 2021 
June 2021  1,2  May 2021 
July 2021  1,2,3,4  June 2021 
August 2021  1,2  July 2021 
September 2021  1,2  August 2021 
October 2021  1,2,3,4  September 2021 
November 2021  1,2  October 2021 
December 2021  1,2  November 2021 
January 2022  1,2,3,4  December 2021 
February 2022  1,2  January 2022 
March 2022  1,2  February 2022 
April 2022  1,2,3,4  March 2022 
 
 
 
DATA COLLECTION SHEET FOR VALPROATE PRESCRIPTIONS (MONTHLY)
 
DATA COLLECTION SHEET FOR ANTIPYSCHOTIC PRESCRIPTIONS (QUARTERLY)
 
List of antipsychotic drugs as specified in section 3.6 of chapter 4 of the BNF April 2021